Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells
Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells Brief Summary:The purpose of this study is to investigate the potential use of Wharton’s Jelly Mesenchymal stem cells (WJ-MSCs) for treatment of patient diagnosed with Corona Virus SARS-CoV-2 infection, and showing symptoms of COVID-19. Condition or disease Intervention/treatment Phase Use of Stem Cells for Read more













